RJA
MSGS icon

Raymond James & Associates’s Madison Square Garden MSGS Stock Holding History

Raymond James & Associates’s Portfolio MSGS Stock Details MSGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.22M Buy
10,649
+931
+10% +$187K ﹤0.01% 2159
2024
Q2 		$1.83M Sell
9,718
-518
-5% -$96K ﹤0.01% 2221
2024
Q1 		$1.89M Buy
10,236
+1,105
+12% +$205K ﹤0.01% 2196
2023
Q4 		$1.66M Buy
9,131
+61
+0.7% +$10.6K ﹤0.01% 2210
2023
Q3 		$1.6M Buy
9,070
+1,034
+13% +$195K ﹤0.01% 2149
2023
Q2 		$1.51M Buy
8,036
+1,372
+21% +$259K ﹤0.01% 2236
2023
Q1 		$1.3M Buy
6,664
+2,010
+43% +$374K ﹤0.01% 2289
2022
Q4 		$853K Buy
4,654
+1,268
+37% +$199K ﹤0.01% 2529
2022
Q3 		$463K Buy
3,386
+247
+8% +$38.3K ﹤0.01% 2919
2022
Q2 		$474K Sell
3,139
-35
-1% -$5.68K ﹤0.01% 2952
2022
Q1 		$569K Buy
3,174
+1,956
+161% +$333K ﹤0.01% 2999
2021
Q4 		$212K Sell
1,218
-6
-0.5% -$1.09K ﹤0.01% 3660
2021
Q3 		$228K Sell
1,224
-118
-9% -$20.2K ﹤0.01% 3592
2021
Q2 		$232K Sell
1,342
-1,460
-52% -$264K ﹤0.01% 3599
2021
Q1 		$503K Buy
2,802
+38
+1% +$7K ﹤0.01% 3017
2020
Q4 		$509K Sell
2,764
-98
-3% -$16.1K ﹤0.01% 2795
2020
Q3 		$431K Sell
2,862
-9,182
-76% -$1.44M ﹤0.01% 2739
2020
Q2 		$1.77M Buy
12,044
+102
+0.9% +$16.8K ﹤0.01% 1808
2020
Q1 		$1.8M Buy
11,942
+626
+6% +$121K ﹤0.01% 1632
2019
Q4 		$2.37M Buy
11,316
+7,109
+169% +$1.39M ﹤0.01% 1725
2019
Q3 		$791K Sell
4,207
-2,253
-35% -$442K ﹤0.01% 2328
2019
Q2 		$1.29M Sell
6,460
-1,108
-15% -$236K ﹤0.01% 2070
2019
Q1 		$1.58M Sell
7,568
-2,574
-25% -$523K ﹤0.01% 1925
2018
Q4 		$1.94M Buy
10,142
+2,068
+26% +$402K ﹤0.01% 1683
2018
Q3 		$1.82M Sell
8,074
-2,906
-26% -$645K ﹤0.01% 1873
2018
Q2 		$2.43M Sell
10,980
-861
-7% -$159K ﹤0.01% 1631
2018
Q1 		$2.08M Buy
11,841
+402
+4% +$65K ﹤0.01% 1678
2017
Q4 		$1.72M Sell
11,439
-118
-1% -$18.2K ﹤0.01% 1779
2017
Q3 		$1.76M Buy
11,557
+362
+3% +$54.8K ﹤0.01% 1725
2017
Q2 		$1.57M Buy
11,195
+548
+5% +$77.5K ﹤0.01% 1750
2017
Q1 		$1.52M Buy
10,647
+2,337
+28% +$304K ﹤0.01% 1704
2016
Q4 		$1.02M Buy
+8,310
New +$1.01M ﹤0.01% 1917

Other funds holding MSGS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Raymond James & Associates's MSGS Position: Q3 2024 in Review

Raymond James & Associates increased its Madison Square Garden (MSGS) stake by 9.6% in Q3 2024, buying an estimated $187K and bringing the position to 10,649 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Raymond James & Associates first reported a position in MSGS in Q4 2016 and has held it in 32 quarters since. The position peaked at $2.43M in Q2 2018. 326 funds tracked by Wall St. Rank hold MSGS as of Q3 2024.

  • Raymond James & Associates held 10,649 shares of Madison Square Garden worth $2.22M as of Q3 2024.
  • Raymond James & Associates bought 931 Madison Square Garden shares in Q3 2024, an estimated $187K.
  • Madison Square Garden made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2159 holding.
  • Raymond James & Associates first reported a position in Madison Square Garden in Q4 2016 and has held it in 32 quarters since.
  • Raymond James & Associates's Madison Square Garden position peaked at $2.43M in Q2 2018.
  • 326 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.